Additional Clarification to Chapter 17, Section 40, Regarding Processing of Drug Claims with the JW Modifier
Provider Types Affected
Physicians, providers, and suppliers billing Medicare Contractors (Medicare Administrative Contractors (A/B MAC), fiscal intermediaries (FI), carriers and/or Durable Medical Equipment Medicare Administrative Contractors (DME MAC) for drugs or biologicals provided to Medicare beneficiaries
Impact on Providers
When processing all drugs except those provided under the Competitive Acquisition Program (CAP) for Part B drugs and biologicals, Medicare contractors may require the use of the modifier JW to identify unused drug or biologicals from single use vials or single use packages that are appropriately discarded. This modifier will provide payment for the discarded drug or biological.
Background
The Centers for Medicare & Medicaid Services (CMS) issued this CR 5923 to notify providers of the Medicare Claims Processing Manual update that clarifies the use of the JW modifier when processing all drugs except CAP drugs.
Additional Information
To see the official instruction (CR5923) issued to your Medicare carrier, DME/MAC, FI, and/or A/B MAC, visit http://www.cms.hhs.gov/Transmittals/downloads/R1478CP.pdf on the CMS Web site.
If you have questions, please contact your Medicare carrier, DME/MAC, FI, and/or A/B MAC at their toll-free number which may be found at http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
Disclaimer This article was prepared as a service to the public and is not intended to grant rights or impose obligations. This article may contain references or links to statutes, regulations, or other policy materials. The information provided is only intended to be a general summary. It is not intended to take the place of either the written law or regulations. We encourage readers to review the specific statutes, regulations and other interpretive materials for a full and accurate statement of their contents.
|